5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.99▲ | 0.99▼ | 0.99▼ | 1.02▼ | 1.03▼ |
MA10 | 1.02▼ | 1.02▼ | 1.02▼ | 1.03▼ | 1.01▼ |
MA20 | 1.03▼ | 1.03▼ | 1.03▼ | 1.06▼ | 1.10▼ |
MA50 | 1.04▼ | 1.02▼ | 1.04▼ | 1.00▼ | 1.74▼ |
MA100 | 1.02▼ | 1.07▼ | 1.07▼ | 1.13▼ | 1.39▼ |
MA200 | 1.09▼ | 1.00▼ | 1.02▼ | 1.73▼ | 18.47▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | -0.007▼ | -0.006▼ | -0.011▼ | 0.032▲ |
RSI | 36.113▼ | 38.453▼ | 38.971▼ | 44.404▼ | 42.110▼ |
STOCH | 4.157▼ | 7.828▼ | 7.828▼ | 36.510 | 45.424 |
WILL %R | -93.867▼ | -93.867▼ | -93.867▼ | -73.845 | -59.729 |
CCI | -85.157 | -103.665▼ | -104.159▼ | -110.900▼ | -19.133 |
Thursday, June 12, 2025 05:00 PM
Elray has completed the sale of proprietary technology to 180 Life Sciences Corp. (NASDAQ:ATNF), a NASDAQ-listed company in exchange for preferred stock convertible into a 40% stake in ATNF and ...
|
Thursday, June 05, 2025 10:29 AM
Abercrombie & Fitch (NYSE:ANF) recently posted mixed financial results for Q1 2025, which included a year-over-year sales increase to $1,097 million, but a decrease in net income. The company also ...
|
Thursday, May 29, 2025 05:04 AM
Good day, and welcome to the Abercrombie & Fitch Co. First Quarter Fiscal Year 2025 Earnings Call. At this time, all participants are in a listen-only mode. […] ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 0.99 | 1.00 | 0.97 | 0.985 | 6,200 |
12/06/25 | 0.99 | 1.017 | 0.95 | 1.00 | 9,600 |
11/06/25 | 1.03 | 1.07 | 0.958 | 0.99 | 115,700 |
10/06/25 | 1.035 | 1.045 | 1.03 | 1.045 | 16,879 |
09/06/25 | 1.07 | 1.07 | 1.01 | 1.06 | 27,600 |
06/06/25 | 1.09 | 1.09 | 1.03 | 1.04 | 27,700 |
05/06/25 | 1.09 | 1.09 | 1.03 | 1.05 | 18,500 |
04/06/25 | 1.04 | 1.071 | 1.04 | 1.069 | 6,900 |
03/06/25 | 1.10 | 1.10 | 1.008 | 1.04 | 9,805 |
02/06/25 | 1.04 | 1.0868 | 1.04 | 1.06 | 19,342 |
|
|
||||
|
|
||||
|
|